Dr. Patrick Forde, MD
Claim this profileJohns Hopkins University/Sidney Kimmel Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
19 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage I
Stage III
2Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Patrick Forde, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Patrick Forde, MD
Clinical Trial Related10 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Patrick Forde, MD has experience with
- Nivolumab
- Carboplatin
- Paclitaxel
- Durvalumab
- Pembrolizumab
- Ipilimumab
Breakdown of trials Patrick Forde, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Malignant Pleural Mesothelioma
Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Forde, MD specialize in?
Patrick Forde, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Patrick Forde, MD currently recruiting for clinical trials?
Yes, Patrick Forde, MD is currently recruiting for 4 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Patrick Forde, MD has studied deeply?
Yes, Patrick Forde, MD has studied treatments such as Nivolumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Patrick Forde, MD?
Apply for one of the trials that Patrick Forde, MD is conducting.
What is the office address of Patrick Forde, MD?
The office of Patrick Forde, MD is located at: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University/Sidney Kimmel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.